heat News and Research

RSS

Full genetic blueprint of multiple prostate tumors laid bare

For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie the disease. The study, made possible by key advances in whole genome sequencing and analysis, points to several new prostate cancer genes and a critical category of genomic changes as important drivers of prostate cancer growth.

10 Feb 2011

New laser device fights cellulite from under the skin

Over 80% of women today live with the reality of having cellulite, making it one of the biggest cosmetic problems plaguing doctors and patients alike. And while there is everything from quick fixes to extensive invasive procedures to lessen this embarrassing condition, we all wait with anticipation for that modern, miracle treatment that permanently makes our dimpled skin vanish while allowing us to maintain our regular schedules.

10 Feb 2011

BeneChill, Physio-Control to launch RhinoChill IntraNasal Cooling System in Europe

Physio-Control, a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, and BeneChill, a pioneer in portable therapeutic cooling systems, today announced a strategic partnership to launch the RhinoChill IntraNasal Cooling System in Europe.

9 Feb 2011

UW research receives Keck Foundation grant to restore lost brain function using neurochips

Tiny, implantable computers that would restore brain function lost to disease or injury is the goal of University of Washington research recently funded by a $1 million, three-year grant from the W.M. Keck Foundation.

9 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others in the U.S. and Japan.

8 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

7 Feb 2011

Dermatologist's tips to reverse damage and maintain healthy, lustrous hair

While the latest hairstyles and hair colors may look great, dermatologists warn that many women are subjecting their hair to harsh chemicals and heated styling devices that, in turn, can damage the hair. Over time, lustrous hair can look lackluster, become brittle and require a complete hair care overhaul to improve hair health and appearance.

5 Feb 2011

Miracle baby after radical new procedure for uterine fibroids

Amy Cordle is the first woman in Australia to become a mother after undergoing a radical new procedure. On Australia Day, the 31-year-old Albert Park woman’s little “miracle” arrived when daughter Neroli was born.

3 Feb 2011

Scientia Advisors: Unmet need for new medical technologies to treat CVI and blood clots

In light of an aging population and increasing chronic vascular disease, there is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors review of the vascular device market released today. Both the CVI and the thrombosis segments present significant opportunities for medical device innovators.

3 Feb 2011

Food scientists pinpoint complex chemistry behind coffee's antioxidant benefits

Food scientists at the University of British Columbia have been able to pinpoint more of the complex chemistry behind coffee's much touted antioxidant benefits, tracing valuable compounds to the roasting process.

3 Feb 2011

Bioengineers and physician-scientists zap tumors with light-activated nanoparticles

Rice University bioengineers and physician-scientists at Baylor College of Medicine and Texas Children's Hospital have successfully destroyed tumors of human brain cancer cells in the first animal tests of a minimally invasive treatment that zaps glioma tumors with heat. The tests involved nanoshells, light-activated nanoparticles that are designed to destroy tumors with heat and avoid the unwanted side effects of drug and radiation therapies.

2 Feb 2011

Scientists discover breast cancer cells that dodge immune system, promote tumor growth

Scientists discovered a new way breast cancer cells dodge the immune system and promote tumor growth, providing a fresh treatment target in the fight against the disease. While comparable mechanisms to avoid the immune system have been identified in mice with breast and other cancers, the study tested human breast tumor cells, putting researchers closer to understanding how the disease progresses in real patients.

2 Feb 2011

The latest example of corporate preparations for health law changes

The Wall Street Journal details how the restaurant chain Chili's is preparing for how its bottom line could be impacted by the health overhaul. Even so, The New York Times reports, a consulting firm concludes that current worries about the well-being of private health insurance are "misplaced."

29 Jan 2011

First Edition: January 28, 2011

Today's headlines include reports that President Obama is expected to really the health reform troops in a speech today.

28 Jan 2011

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.

28 Jan 2011

Opinions: Global poverty; Global Fund corruption; Tackling poverty, environmental issues

Ahead of the World Economic Forum in Davos, Switzerland, Laurence Chandy and Geoffrey Gert, both of the Brookings Institution's Global Economy and Development program, reflect on "Poverty's Success Story," a Washington Post opinion piece. They note that the last time the World Bank issued global poverty statistics (the number of people in the world living on less than $1.25 each day) was 2005.

28 Jan 2011

Interim results from ganetespib Phase 2 trial in NSCLC to be presented at 11th IASLC annual meeting

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Jonathan Goldman, M.D., Premiere Oncology will present interim results from a Phase 2 trial of ganetespib in non-small cell lung cancer at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.

28 Jan 2011

Government's health care fraud prevention and enforcement efforts recover over $4 billion in FY 2010

U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius and U.S. Associate Attorney General Thomas J. Perrelli today announced a new report showing that the government's health care fraud prevention and enforcement efforts recovered more than $4 billion in taxpayer dollars in Fiscal Year (FY) 2010.

25 Jan 2011

Research finds faster developmental rate incurs lethal physiological costs for individuals

Fast development is often perceived as an advantage, as it enables better harmony with one's environment and readiness to cope with the challenges that it poses. However, research conducted at the University of Haifa, Israel, and University of California, Santa Cruz, and published in the scientific journal PLoS ONE, found that the acceleration of developmental rate incurs potentially lethal physiological costs for the developing individual.

25 Jan 2011

UWE researcher receives two CSPCT grants to improve clinical delivery of treatments

A researcher from the University of the West of England has been awarded two grants to fund work that will encourage people with serious joint conditions to move and excercise more.

24 Jan 2011

heat News and Research

Full genetic blueprint of multiple prostate tumors laid bare

New laser device fights cellulite from under the skin

BeneChill, Physio-Control to launch RhinoChill IntraNasal Cooling System in Europe

UW research receives Keck Foundation grant to restore lost brain function using neurochips

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

Dermatologist's tips to reverse damage and maintain healthy, lustrous hair

Miracle baby after radical new procedure for uterine fibroids

Scientia Advisors: Unmet need for new medical technologies to treat CVI and blood clots

Food scientists pinpoint complex chemistry behind coffee's antioxidant benefits

Bioengineers and physician-scientists zap tumors with light-activated nanoparticles

Scientists discover breast cancer cells that dodge immune system, promote tumor growth

The latest example of corporate preparations for health law changes

First Edition: January 28, 2011

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

Opinions: Global poverty; Global Fund corruption; Tackling poverty, environmental issues

Interim results from ganetespib Phase 2 trial in NSCLC to be presented at 11th IASLC annual meeting

Government's health care fraud prevention and enforcement efforts recover over $4 billion in FY 2010

Research finds faster developmental rate incurs lethal physiological costs for individuals

UWE researcher receives two CSPCT grants to improve clinical delivery of treatments

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News